For example, VEGF-C activated tumor-specific T cells by promoting lymphangiogenesis in glioblastoma multiforme (GBM), which increased the anti-tumor effects of anti-PD-1 and prolonged the survival of mice [60]. The gene discussed is VEGFC; the disease is glioblastoma.